Myricitrin alleviates MPP+-induced mitochondrial dysfunction in a DJ-1-dependent manner in SN4741 cells

Biochemical and Biophysical Research Communications

Volumn 458, Issue 2, 2015, Pages 227-233

  Cai, Zhibiao ^a   Zeng, Weijun ^a   Tao, Kai ^a   Lu, Fangfang ^a   Gao, Guodong ^a   Yang, Qian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DJ 1; Mitochondria; Myricitrin; Neuronal death; Parkinson's disease

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; DJ 1 PROTEIN; FLAVANOID; MYRICITRIN; NEUROTOXIN; UNCLASSIFIED DRUG; 1 METHYL 4 PHENYLPYRIDINIUM; ANTIOXIDANT; DJ-1 PROTEIN, MOUSE; FLAVONOID; NEUROPROTECTIVE AGENT; ONCOPROTEIN; PEROXIREDOXIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LINE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; NERVE CELL; PHYSIOLOGY;

MORELLA CERIFERA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLAVONOIDS; MICE; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; ONCOGENE PROTEINS; PEROXIREDOXINS;

EID: 84923311456     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.060     Document Type: Article

References (26)

1. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain J. Neurol. 114 Pt 5 1991 2283 2301
2. O. Hornykiewicz, and S.J. Kish Biochemical pathophysiology of Parkinson's disease Adv. Neurol. 45 1987 19 34
3. C. Henchcliffe, and M.F. Beal Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat. Clin. Pract. Neurol. 4 2008 600 609
4. M.P. Mattson, M. Gleichmann, and A. Cheng Mitochondria in neuroplasticity and neurological disorders Neuron 60 2008 748 766
5. X. Tao, and L. Tong Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease J. Biol. Chem. 278 2003 31372 31379
6. P.J. Kahle, J. Waak, and T. Gasser DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders Free Radic. Biol. Med. 47 2009 1354 1361
7. M.K. McCoy, and M.R. Cookson DJ-1 regulation of mitochondrial function and autophagy through oxidative stress Autophagy 7 2011 531 532
8. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, E. Krieger, M.C. Dekker, F. Squitieri, P. Ibanez, M. Joosse, J.W. van Dongen, N. Vanacore, J.C. van Swieten, A. Brice, G. Meco, C.M. van Duijn, B.A. Oostra, and P. Heutink Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Sci. (New York N.Y.) 299 2003 256 259
9. D.W. Miller, R. Ahmad, S. Hague, M.J. Baptista, R. Canet-Aviles, C. McLendon, D.M. Carter, P.P. Zhu, J. Stadler, J. Chandran, G.R. Klinefelter, C. Blackstone, and M.R. Cookson L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system J. Biol. Chem. 278 2003 36588 36595
10. J. Choi, M.C. Sullards, J.A. Olzmann, H.D. Rees, S.T. Weintraub, D.E. Bostwick, M. Gearing, A.I. Levey, L.S. Chin, and L. Li Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases J. Biol. Chem. 281 2006 10816 10824
11. B.D. Paul, G.S. Rao, and G.J. Kapadia Isolation of myricadiol, myricitrin, taraxerol, and taraxerone from Myrica cerifera L. root bark J. Pharm. Sci. 63 1974 958 959
12. S.J. Wang, Y. Tong, S. Lu, R. Yang, X. Liao, Y.F. Xu, and X. Li Anti-inflammatory activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves Planta Medica 76 2010 1492 1496
13. J. Bao, Y. Cai, M. Sun, G. Wang, and H. Corke Anthocyanins, flavonols, and free radical scavenging activity of Chinese bayberry (Myrica rubra) extracts and their color properties and stability J. Agric. Food Chem. 53 2005 2327 2332
14. G.B. Sun, M. Qin, J.X. Ye, R.L. Pan, X.B. Meng, M. Wang, Y. Luo, Z.Y. Li, H.W. Wang, and X.B. Sun Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice Toxicol. Appl. Pharmacol. 271 2013 114 126
15. F.C. Meotti, F.C. Missau, J. Ferreira, M.G. Pizzolatti, C. Mizuzaki, C.W. Nogueira, and A.R. Santos Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice Biochem. Pharm. 72 2006 1707 1713
16. Y.-H. Wang, Z.-H. Xuan, S. Tian, G.-R. He, and G.-H. Du Myricitrin attenuates 6-hydroxydopamine-induced mitochondrial damage and apoptosis in PC12 cells via inhibition of mitochondrial oxidation J. Funct. Foods 5 2013 337 345
17. J.H. Son, H.S. Chun, T.H. Joh, S. Cho, B. Conti, and J.W. Lee Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos J. Neurosci. Off. J. Soc. Neurosci. 19 1999 10 20
18. W.J. Koopman, F. Distelmaier, J.J. Esseling, J.A. Smeitink, and P.H. Willems Computer-assisted live cell analysis of mitochondrial membrane potential, morphology and calcium handling Methods (San Diego Calif.) 46 2008 304 311
19. D.J. Moore, L. Zhang, J. Troncoso, M.K. Lee, N. Hattori, Y. Mizuno, T.M. Dawson, and V.L. Dawson Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress Hum. Mol. Gen. 14 2005 71 84
20. I. Irrcher, H. Aleyasin, E.L. Seifert, S.J. Hewitt, S. Chhabra, M. Phillips, A.K. Lutz, M.W. Rousseaux, L. Bevilacqua, A. Jahani-Asl, S. Callaghan, J.G. MacLaurin, K.F. Winklhofer, P. Rizzu, P. Rippstein, R.H. Kim, C.X. Chen, E.A. Fon, R.S. Slack, M.E. Harper, H.M. McBride, T.W. Mak, and D.S. Park Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics Hum. Mol. Gen. 19 2010 3734 3746
21. A. Toulouse, and A.M. Sullivan Progress in Parkinson's disease - where do we stand? Prog. Neurobiol. 85 2008 376 392
22. M. Fukui, H.J. Choi, and B.T. Zhu Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death Free Radic. Biol. Med. 49 2010 800 813
23. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172
24. K. Schmitt, A. Grimm, A. Kazmierczak, J.B. Strosznajder, J. Gotz, and A. Eckert Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio Antioxid. Redox Signal. 16 2012 1456 1466
25. A.H. Schapira Mitochondrial disease Lancet 368 2006 70 82
26. S. Orrenius, V. Gogvadze, and B. Zhivotovsky Mitochondrial oxidative stress: implications for cell death Annu. Rev. Pharmacol. Toxicol. 47 2007 143 183.